TURUNAN-TURUNAN 1,3,5-TRIAZINA TERTRISUBSTITUSI UNTUK PENGOBATAN INFEKSI-INFEKSI HIV

This invention concerns the use of the compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein A is CH or N; n is 0, 1, 2, 3 or 4; and in case A is CH, then n may also be 5; R and R are each independently selected fro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MARC RENE DE JONGE, ROBERT W. KAVASH, FREDERIK F. D. DAEYAERT, DONALD W. LUDOVICI, CHIH YUNG HO, LUCIEN M. H. KOYMANS, MICHAEL J. KUKLA, BART DE CORTE, JAN HEERES, PAUL ADRIAAN JAN JANSSEN
Format: Patent
Sprache:ind
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention concerns the use of the compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein A is CH or N; n is 0, 1, 2, 3 or 4; and in case A is CH, then n may also be 5; R and R are each independently selected from hydrogen, hydroxy, C1-12alkyl, C1-12alkyloxy, C1-12alkylcarbonyl, C1-12alkyloxycarbonyl, aryl, amino, mono- or di(C1-12alkyl)amino, mono- or di(C1-12alkyl)aminocarbonyl wherein each of the aforementioned C1-12alkyl groups may optionally be substituted; or R and R taken together may form pyrrolidinyl, piperidinyl, morpholinyl, azido or mono- or di(C1-12alkyl)aminoC1-4alkylidene; R is hydrogen, aryl, C1-6alkylcarbonyl, optionally substituted C1-6alkyl, C1-6alkyloxycarbonyl; and each R independently is hydroxy, halo, C1-6alkyl, C1-6alkyloxy, cyano, aminocarbonyl, nitro, amino, trihalomethyl or trihalomethyloxy ; R is optionally substituted phenyl; and X is -NR -, -NH-NH-, -N=N-, -O-, -S-, -S(=O)- or -S(=O)2-; aryl is optionally substituted phenyl; Het is an optionally substituted aliphatic or optionally substituted aromatic heterocyclic radical; for the manufacture of a medicine for the treatment of subjects suffering from HIV (Human Immunodeficiency Virus) infection. It further relates to new compounds being a subgroup of the compounds of formula (I), their preparation and compositions comprising them.